NeuroPace
NPCE
NeuroPace (NPCE) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.18
- EPS estimate
- −$0.22
- EPS surprise
- +17.39%
- Revenue surprise
- +0.94%
- Revenue
- $22.8M
- Revenue estimate
- $22.6M
- Reported
- Aug 11, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 11, 2026 | −$0.22 | −$0.18 | +17.39% | $22.8M | SEC |
| Q1 2026 | May 12, 2026 | −$0.23 | −$0.20 | +12.97% | $22.0M | SEC |
| Q4 2025 | Mar 3, 2026 | −$0.16 | −$0.08 | +48.75% | $26.6M | SEC |
| Q3 2025 | Nov 4, 2025 | −$0.20 | −$0.11 | +43.68% | $27.4M | SEC |
| Q2 2025 | Aug 12, 2025 | −$0.22 | −$0.26 | −16.64% | $23.5M | SEC |
| Q1 2025 | May 13, 2025 | −$0.24 | −$0.21 | +12.83% | $22.5M | SEC |
| Q4 2024 | Mar 4, 2025 | −$0.22 | −$0.18 | +19.25% | $21.5M | SEC |
| Q3 2024 | Nov 12, 2024 | −$0.27 | −$0.19 | +29.26% | $21.1M | SEC |
| Q2 2024 | Aug 13, 2024 | −$0.30 | −$0.26 | +13.33% | $19.3M | SEC |
| Q1 2024 | May 8, 2024 | −$0.32 | −$0.32 | +0.40% | $18.1M | SEC |
| Q4 2023 | Mar 5, 2024 | −$0.32 | −$0.23 | +26.98% | $18.0M | SEC |
| Q3 2023 | Nov 6, 2023 | −$0.40 | −$0.28 | +30.69% | $16.4M | SEC |
| Q2 2023 | Aug 8, 2023 | −$0.47 | −$0.36 | +23.40% | $16.5M | SEC |
| Q1 2023 | May 4, 2023 | −$0.46 | −$0.41 | +10.38% | $14.5M | SEC |
| Q4 2022 | Mar 2, 2023 | −$0.50 | −$0.45 | +10.00% | $12.8M | SEC |
| Q3 2022 | Nov 8, 2022 | −$0.53 | −$0.48 | +9.00% | $11.2M | SEC |
| Q2 2022 | Aug 11, 2022 | −$0.45 | −$0.52 | −15.56% | $10.2M | SEC |
| Q1 2022 | May 12, 2022 | −$0.44 | −$0.47 | −6.21% | $11.4M | SEC |
| Q4 2021 | Mar 10, 2022 | −$0.33 | −$0.44 | −33.33% | $11.0M | SEC |
| Q3 2021 | Nov 10, 2021 | −$0.30 | −$0.34 | −11.84% | $10.3M | SEC |
Quarterly revenue
Frequently asked questions
When did NeuroPace (NPCE) last report earnings?
NeuroPace last reported on Aug 11, 2026, covering fiscal Q2 2026.
Did NPCE beat earnings estimates?
Yes. NeuroPace reported EPS of −$0.18 for Q2 2026 against a −$0.22 estimate — a 17.39% beat.
How much revenue did NPCE report last quarter?
NeuroPace reported $22.8M in revenue for Q2 2026, against a consensus estimate of $22.6M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.